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Abstract The matricellular protein CCN2 (Connective
Tissue Growth Factor; CTGF ) is an essential mediator of
ECM composition, as revealed through analysis of Ccn2
deficient mice. These die at birth due to complications
arising from impaired endochondral ossification. However,
the mechanism(s) by which CCN2 mediates its effects in
cartilage are unclear. We investigated these mechanisms
using Ccn2−/− chondrocytes. Expression of type II collagen
and aggrecan were decreased in Ccn2−/− chondrocytes,
confirming a defect in ECM production. Ccn2−/− chondro-
cytes also exhibited impaired DNA synthesis and reduced
adhesion to fibronectin. This latter defect is associated with
decreased expression of α5 integrin. Moreover, CCN2 can
bind to integrin α5β1 in chondrocytes and can stimulate
increased expression of integrin α5. Consistent with an
essential role for CCN2 as a ligand for integrins, immuno-
fluorescence and Western blot analysis revealed that levels
of focal adhesion kinase (FAK) and extracellular signal-
regulated kinase (ERK)1/2 phosphorylation were reduced
in Ccn2−/− chondrocytes. These findings argue that CCN2
exerts major effects in chondrocytes through its ability to
(1) regulate ECM production and integrin α5 expression,
(2) engage integrins and (3) activate integrin-mediated
signaling pathways.
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Interactions of cells with the extracellular matrix (ECM)
play essential roles in morphogenesis and repair (Ekblom
et al. 1986). CCN proteins are matricellular molecules that
have important roles in these processes (Lau and Lam 1999;
Takigawa 2003; Perbal 2004; Perbal and Takigawa 2005;
Rachfal and Brigstock 2005; Kubota and Takigawa 2007).
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CCN2 (Connective tissue growth factor (CTGF)) is a
cysteine-rich, ECM-associated, heparin-binding protein,
with the characteristic structure of CCN proteins: an N-
terminal secretory signal, followed by four modular
domains (Brigstock 2003).
CCN2 is a major inducer of ECM production in fibrotic
disease (Leask and Abraham 2004), but its role in normal
tissues is less well understood. CCN2 is highly expressed in
cartilage and endothelial cells in vivo (Nakanishi et al.
2000; Friedrichsen et al. 2003; Ivkovic et al. 2003).
Previously, we reported that recombinant CCN2 (rCCN2)
promotes the proliferation and differentiation of chondro-
cytes and osteoblasts (Nakanishi et al. 2000). In order to
test the physiological relevance of these activities, we
generated Ccn2-deficient mice (Ivkovic et al. 2003). These
die soon after birth, in part as a result of severe skeletal
abnormalities associated with impaired chondrocyte prolif-
eration and ECM expression (Ivkovic et al. 2003). The
hypertrophic zones of mutants are enlarged, due to
defective remodeling of the cartilage ECM by chondro-
clasts/osteoclasts, impaired invasion by blood vessels, and
subsequent inability to support the formation of an osteoid
matrix by osteoblasts (Ivkovic et al. 2003). These and
other findings indicate that CCN2 promotes endochondral
ossification by enhancing the proliferation and maturation
of chondrocytes, and the survival of invading endothelial
cells (Nakanishi et al. 2000; Ivkovic et al. 2003; Shimo
et al. 1999).
A second member of the CCN family, CCN6, is also
essential for chondrocyte function. Homozygosity for loss-
of-function mutations in Ccn6 leads to progressive pseudo-
rheumatoid dysplasia in humans (Hurvitz et al. 1999). This
disease is a severe form of childhood-onset arthritis, but
nothing is known about the role of CCN6 in normal
cartilage. CCN1 may also have essential functions in
chondrogenesis. Although Ccn1−/− mutants die too early
to examine skeletal development, CCN1 stimulates chon-
drocyte proliferation and ECM accumulation in vitro
(Wong et al. 1997; Mo et al. 2002). Given that multiple
members of the CCN family have essential functions in
chondrogenesis, understanding the mechanisms by which
these proteins function is an important issue.
CCN2 functions as a ligand for integrins in vitro (Lau
and Lam 1999; Babic et al. 1999; Leu et al. 2003; Chen et
al. 2004; Gao and Brigstock 2004; Hoshijima et al. 2006;
Tong and Brigstock 2006). Integrins play a fundamental
role in chondrocyte survival, proliferation and differentia-
tion (Hynes 2002; Loeser 2002). Work from a number of
laboratories has documented the presence of α1β1, α5β1,
α6β1, and αvβ5 integrins in intact cartilage (Loeser 2002).
Of these, α5β1 is thought to be the most abundant of the
β1-containing integrins in fetal cartilage (Häusler et al.
2002). α5β1 integrin plays multiple roles in chondrocyte
survival and function (Enomoto-Iwamoto et al. 1997; Salter
et al. 2001; Pulai et al. 2002; Chen et al. 2005), and cartilage-
specific β1-integrin-deficient mice exhibit profoundly
abnormal growth plate structure (Aszodi et al. 2003). A role
for α5β1 integrin in the decision chondrocytes make
between endochondral ossification and joint formation has
also been suggested (Garciadiego-Cázares et al. 2004). The
collagen binding integrins α1β1 and α10β1 are also
expressed in chondrocytes (Camper et al. 1998; Zemmyo
et al. 2003). Integrin α1−/− mice are prone to osteoarthritis
(Zemmyo et al. 2003) and exhibit impaired cartilage
formation during fracture healing (Ekholm et al. 2002).
Mice deficient in α10 have only minor defects in cartilage
(Bengtsson et al. 2005). Chondrocytes also express integrin
α2 (Kim et al. 2003; Lahiji et al. 2004), but no skeletal
defects have been reported in integrin α2−/− mice (Chen et
al. 2002; Holtkötter et al. 2002). In summary, loss of
function studies reveals roles for integrins α1, α5, α10, and
β1 in intact cartilage, and α5β1 is a key regulator of
multiple aspects of chondrocyte behavior.
We previously reported that Ccn2−/− fibroblasts exhibit
impaired adhesive signaling and defective adhesion to
fibronectin, and that CCN2 is a ligand for α5β1 integrin
in fibroblasts (Chen et al. 2004). CCN2 also regulates
α5β1 integrin expression in rat fibroblasts (Frazier et al.
1996) and human mesangial cells in vitro (Weston et al.
2003). These studies raise the possibility that CCN2 is an
essential ligand for integrins in chondrocytes, and/or reg-
ulates integrin expression. We used Ccn2−/− chondrocytes
to examine these possibilities and their potential relevance
to the chondrodysplasia observed in Ccn2−/− mice.
Materials and methods
Reagents
Dulbecco’s modified Eagle Medium (DMEM) and Mini-
mum Essential (αMEM) Medium Alpha (αMEM) were
purchased from Invitrogen (Grand Island, NY); fetal bovine
serum (FBS) was from Omega Scientific (Tarzana, CA).
Plastic dishes and plates were obtained from Becton-
Dickinson (Frabkin Lakes, NJ). Isotopes were from ICN
Biomedicals (Aurora, OH) and PerkinElmer, (Boston, MA).
Trizol reagent was from Invitrogen; X-ray films were from
Kodak (Rochester, NY). Anti-ERK1/2, anti-phospho-
ERK1/2, and anti-phoshpho-MEK1/2 were from Cell
Signaling Technology (Beverly, MA); anti-FAK, anti-
phospho-FAK, anti-integrin α5β1 for immunoprecipita-
tion (MAB1969), and anti-integrin α5 for Western
blotting (AB1921) and anti-vimentin were from Chemicon
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(Temecula, CA), anti-aggrecan was from Abcam (Cambridge,
MA); anti-collagen type II was from Cosmo Bio (Tokyo,
Japan); anti-β-actin was from Sigma (St Louis, MO); anti-
phospho-tyrosine was from Zymed (San Francisco, CA).
Alexa fluor conjugated phalloidin was fromMolecular Probes
(Eugene, OR). Anti-CTGF/CCN2 serum was as described
previously (Nakanishi et al. 2000). Fibronectin (FN) and
vitronectin (VN) were from Sigma. rCCN2 was prepared as
described (Asano et al. 2005).
Isolation of chondrocytes
Primary cultures of chondrocytes isolated from the ventral
half of the rib cage of embryos were prepared as described
previously (Lefebvre et al. 1994). Briefly, rib cages and
sterna were dissected from E18.5 embryos, rinsed in
phosphate-buffered saline (PBS), and incubated at 37°C
for 1 h in 2 mg/ml pronase E (Sigma) in PBS, rinsed again
with PBS, and then incubated with bacterial collagenase
(3 mg/ml: collagenase D; Sigma) in DMEM at 37°C under
7.5% CO2 for 1 h until soft tissues detached from the
cartilage after gentle titration. The cartilage was then further
digested with collagenase D for 2 h. Residual bony parts
were discarded. The remaining cell suspension was filtered
through a 70-μm cell strainer (Becton Dickinson) and
rinsed in αMEM containing 10% serum. The isolated
chondrocytes were seeded at a density of 1×105 cells/cm2
into 6-well multiplates in αMEM containing 10% FBS, and
were then cultured at 37°C under 5% CO2. Cells derived
from each embryo were plated out independently, and tail
samples were collected for genotyping.
Adhesion assays
Tissue culture plates (96-well multiplates) were coated with
bovine serum albumin (BSA), FN, or VN by incubation
overnight at 37°C in 10 μl of PBS containing 5 μg of the
protein. The coated plates were then blocked with 1% BSA
for 1 h at 37°C, and washed with PBS. For the adhesion
assay in Fig. 4c, 96-well plates coated with rCCN2 (5 μg/
well) overnight at 37°C. The coated plates were then
blocked with a 1:10 dilution of anti-α5 integrin antibody
(AB1921, Chemicon) or normal rabbit anti-serum for 1 h at
37°C, and washed with PBS. First passage mouse chon-
drocytes were inoculated at a density of 5×104/well and
maintained in αMEM containing 10% FBS. After 60 min,
cultures were washed five times with PBS, fixed in 3.5%
formaldehyde for 30 min, and stained with 0.5% crystal
violet solution (J.T. Baker Chemical, Phillipsburg, NJ) for
30 min. Chondrocyte adhesion was quantified by dye
extraction and measurement of absorbance at 550 nm.
Northern blot analysis
Total RNA was prepared using Trizol reagent (Invitrogen).
Ten μg of total RNA was subjected to electrophoresis
on a 1% formaldehyde-agarose gel and transferred onto
Hybond-N+filters (Amersham Pharmacia Biotech). Northern
blot analysis was performed as described previously (Nishida
et al. 2000, 2002). Oligo-labeled probes for mouse Ccn2, and
Collagen type II (Col2A1) were used as described (Nishida
et al. 2002); a probe for mouse aggrecan was amplified
using the following gene-specific primers: (Gen Bank
accession no. NM_007424; expected size; 197 bp), forward
cggtaccctacagagacacttcaaga and reverse gtgaccctggaacttggt
ccaccc.
Real-time reverse transcriptase (RT)-PCR analysis
Quantitative real-time polymerase chain reaction (PCR)
was performed by using a LightCycler (Roche; Mannheim,
Germany). The primer sequences were as follows: integrin
α1 (NM_001033228 expected size 513 bp) forward
ttctgatgtcagccctacatt and reverse atagctatggaaaatcgctgaa
integrin α2 (NM_008396 expected size 244 bp) forward
t g c t gg c t g a a a g a c c t t c a c a t g a nd r e v e r s e g a t a a
cccctgtcggtacttct; integrin α5 (NM_010577; expected size;
544 bp) forward agcgcatctctcaccatctt and reverse tcaggtt
cagtgcgttcttgt; integrin α10 (XM_925721; expected size;
592 bp) forward tggagtctctctccatcc and reverse tcgatgaa
cagtcttcctaccagc; integrin β1 (NM_010578; expected size;
451 bp) forward tgttcagtgcagagccttca and reverse cctca
tacttcggattgacc; and GAPDH (NM_062046.3; expected
size; 171 bp) forward acc-aggtggtctcctctgacttcaa and
reverse tactccttggaggccatgt-ggg. forward accaggtggtctc
ctctgacttcaa and reverse tactccttggaggccatgtggg. Total
RNA was reverse-transcribed to cDNA with SuperScript™
III First-Strand Synthesis System for RT-PCR (Invitrogen).
Amplification reactions were performed with a SYBR®
Green Real-time PCR Master Mix (Toyobo; Tokyo, Japan).
Western blotting
Chondrocytes were plated on BSA, FN, or VN and
maintained in αMEM containing 10% FBS for the
indicated times. In some experiments, rCCN2 (50 ng/ml)
and/or cycloheximide (20 μg/ml; Sigma) was added to
the culture medium. Proteins separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) were transferred to an Immobilon-P mem-
brane (Millipore) using a tank transfer apparatus (Bio-
Rad, Hercules, CA). Cell lysates were prepared and
western blot analysis was carried out essentially as
described (Kubota et al. 2000).
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Evaluation of DNA synthesis and proteoglycan production
Mouse chondrocytes were inoculated at a density of 5×104/
well into 24-well multiplates, and cultured in αMEM
containing 10% FBS for up to 2 days. For determination
of cell proliferation, [3H] thymidine incorporation assays
were performed on day 0 (2 h after inoculation), 1, and 2.
[3H] thymidine (37 MBq/ml, PerkinElmer) was added to
the cultures at a final concentration of 370 kBq/ml, and
incubation was continued for 4 h. After labeling, cells were
harvested and incorporation of radioactivity was deter-
mined using liquid scintillation counting. For determination
of proteoglycan production, chondrocytes were cultured on
chamber slides and stained for alcian blue or toluidine blue
as described previously (Atsumi et al. 1990). To quantify
the intensity of the staining, the dye was extracted with
1 ml lysis buffer (0.15 M NaCl, 50 mM Tris-HCl (pH 7.5),
3 mM MgCl2, 1 mM CaCl2, 1% Triton X-100) overnight at
room temperature. The optical density of extracted dye was
measured at 600 nm.
Immunoprecipitation analysis
Immunoprecipitation analysis was performed by a modifi-
cation of a method described previously (Nishida et al.
2004). Briefly, cell layers were solubilized in lysis buffer
and a mixture of protease inhibitors. Lysates were immu-
noprecipitated with antibody or heparin sepharose over-
night at 4°C. Antibody complexes samples were collected
by incubation with protein G-sepharose (Roche, Mannheim,
Germany). Pellets were washed three times with ice-cold
PBS, and precipitated proteins were solubilized in reducing
SDS sample buffer. Samples were electrophoresed on SDS-
polyacrylamide gels and subjected to Western blot analysis.
Indirect immunofluorescence analysis
Cells were inoculated on chamber slides (Nunc Inc.,
Naperville, IL) coated with FN. After 4 h, cultures were
washed with PBS, fixed with 3.5% formaldehyde for
30 min at room temperature, and permeabilized with 0.1%
NP-40 in PBS. Indirect immunofluorescence analysis was
performed as described previously (Aszodi et al. 2003).
Images were obtained using either a confocal laser scanning
microscope (Bio-Rad) or a light microscope (Zeiss).
Immunohistochemistry
Mouse femurs were dissected and fixed in 10% formalin
overnight at 4°C before being embedded in paraffin.
Five micrometer longitudinal sections were mounted on
glass slides, deparaffinized and treated with hyaluronidase
(25 mg/ml) for 30 min at room temperature. Immunohis-
tochemistry was performed with a Histofine kit (Nichirei;
Tokyo, Japan). Color was developed with diaminobenzine,
and sections were counterstained with methyl green.
Control specimens incubated with diluted non-immune
antibody showed no detectable signals.
Statistical analysis
Unless otherwise specified, all experiments were repeated
at least twice, and similar results were obtained. Statistical
analysis was performed by Student’s t test. Densitometry
was performed using NIH ImageJ (Version 1.38 m).
Results
Characterization of chondrocytes derived from CCN2
mutant mice
Chondrocytes were isolated from rib cages of E18.5 wild
type (WT), Ccn2+/−, and Ccn2−/− mice. Cells isolated from
mutant and WT mice displayed a typical chondrocyte
morphology, and no differences were observed in Ccn2−/−
chondrocytes compared to WT or heterozygous cells
(Fig. 1a). It has been reported that recombinant CCN2
protein promotes chondrocyte proliferation and differentia-
tion (Nakanishi et al. 2000). Therefore, we investigated
whether proliferation and/or differentiation were impaired
in Ccn2−/− chondrocytes. A significant decrease in [3H]
thymidine incorporation was observed in Ccn2−/− chon-
drocyte cultures compared to WT cells (Fig. 1b). These data
demonstrate that CCN2 is required for normal rates of
chondrocyte proliferation. The effect of loss of Ccn2 on
differentiation was examined by staining with toluidine
blue and alcian blue to visualize cartilage matrix proteo-
glycans. As shown in Fig. 1c, staining with both dyes was
decreased in Ccn2−/− chondrocytes; absorbance at 600 nm
of extracted alcian blue shows that Ccn2−/− chondrocytes
exhibit an approximately 50% decrease in proteoglycan
content compared to WT cells. Therefore, ECM production
is significantly impaired in Ccn2−/− chondrocytes.
To further investigate defects in ECM production in
Ccn2−/− chondrocytes, we examined the levels of expres-
sion of specific markers. Ccn2−/− mRNA (Fig. 2a) and
protein (Fig. 2b) were undetectable in Ccn2−/− chondro-
cytes, confirming that the previously described targeted
Ccn2 mutation encodes a null allele (Ivkovic et al. 2003).
Expression of both type II collagen and aggrecan mRNA
and protein were decreased in Ccn2−/− chondrocytes, com-
pared with WT cells (Fig. 2a,b; Fig. S1a, Supplementary
data). Densitometric analysis confirmed that type II
collagen and aggrecan protein levels were substantially
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lower in Ccn2−/− chondrocytes (Fig. 2c). Impaired type II
collagen production in Ccn2−/− cartilage has not been
previously reported. Therefore, to confirm decreased
expression of type II collagen, we performed immunoflu-
orescence on WT and Ccn2−/− chondrocytes. Figure 2d
shows that few Ccn2−/− chondrocytes express normal
levels of type II collagen. These data are consistent with
previous studies showing that exogenous CCN2 enhances
Fig. 2 Effect of CCN2 on chondrocyte proliferation and differenti-
ation. Expression of Ccn2, Col2A1, and aggrecan in chondrocytes.
a RNA was isolated from confluent cultures of chondrocytes and
analyzed by Northern blot. The bottom panel shows methylene blue
staining for ribosomal RNAs as a loading control. b Western blot
analysis of CCN2, collagen type II, and aggrecan protein in whole
lysates of confluent chondrocytes. The bottom panel shows β-actin as
a loading control. c Densitometric analysis of protein levels of type II
collagen (left panel) and aggrecan (right panel). WT levels are set at
1.0, and the relative ratio of expression in Ccn2−/− chondrocytes is
indicated. Data shown are from a representative experiment.
d Immunofluorescence analysis of type II collagen expression.
Confocal laser scanning immunofluorescent and corresponding phase
contrast images are shown for WT and Ccn2−/− chondrocytes. The bar
represents 30 μm. The Northern, Western, and immunofluorescence
analyses were repeated three times with similar results. Representative
experiments are shown
Fig. 1 Morphology and expression of cartilage markers in Ccn2−/−
chondrocytes. a Photomicrographs of mouse chondrocytes. Chondro-
cytes were grown after one passage until confluent. Bar 200 μm. b
Ccn2+/+ (filled circle), Ccn2+/− (open square), and Ccn2−/− (filled
square) chondrocytes were inoculated at a density of 5×104/well in
24-well plates, and cultured in αMEM containing 10% FBS. [3H]
thymidine incorporation assays were performed on days 0 (2 h after
plating), 1, and 2. Each point shows the mean and S.D. for four wells.
Asterisks indicate significant differences between WT and Ccn2−/−
cells at the significance level of p<0.01. c WT and Ccn2−/−
chondrocytes were cultured until confluent. Duplicate cultures of the
cells were fixed in 3.5% formaldehyde, and stained with 0.05%
toluidine blue or 1% alcian blue. For quantification of alcian blue
staining (right panel), stained chondrocytes were dissolved in lysis
buffer, and the absorbance was measured at 600 nm. The asterisk
indicates a significant difference between WT and Ccn2−/− chondro-
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ECM production in chondrocytes in vitro (Nakanishi et al.
2000). Consistent with the persistence of some type II
collagen in protein lysates prepared from Ccn2−/− chon-
drocytes (Fig. 2b), type II collagen can occasionally be
detected in Ccn2−/− cells by immunohistochemistry (Fig.
S1b, Supplementary data). In contrast to the reduced
Fig. 3 Downregulation of α5 integrin expression and reduced
adhesion of Ccn2−/− chondrocytes. a Expression of integrins α1, α5,
α10, and β1 in WT and Ccn2−/− chondrocytes. WT and Ccn2−/−
chondrocytes were cultured until confluent. Total RNA was collected
and quantitative real-time RT-PCR analysis was performed. Data
presented are mean and S.D. relative to WT (relative expression=1.0),
of two separate reactions using mRNA from two different cultures.
The asterisk indicates significance at p<0.05. b Western blot analysis
of integrin α5 protein in lysates of WT and Ccn2−/− chondrocytes
spread on FN for the indicated times. Levels of integrin α5 are
decreased in Ccn2−/− chondrocytes beginning at the earliest stage
monitored. c Effect of rCCN2 on the expression of integrin α5 in WT
and Ccn2−/− chondrocytes. WT and Ccn2−/− cells were cultured until
confluent. Thereafter, the medium was replaced with a serum-free
medium containing rCCN2 at 50 ng/ml, and total RNA was collected
6 h later. Top panel: Northern blot analysis was performed using a
probe specific for integrin α5, and methylene blue staining for the
ribosomal subunits. Bottom panel: The amount of integrin α5 mRNA
was determined densitometrically and normalized to 18S-ribosomal
RNA. Data presented are mean and S.D. relative to WT using mRNA
from two different experiments. The asterisk indicates significance at
p<0.05. d Cell attachment assay. WT and Ccn2−/− chondrocytes were
inoculated at a density of 5×104/well in 96-well plates coated with FN
or BSA (each 5 μg/well) overnight. The ordinate shows the relative
ratio of adhesion normalized to BSA (=1). Each column represents the
mean and S.D. of 10 wells. The asterisks indicate a significant
difference (p<0.05) between WT and Ccn2−/− chondrocytes. e Effect
of VN on integrin α5 expression. WT and Ccn2−/− chondrocytes were
plated at a density of 2×105/well in 6-well plates coated with VN.
Levels of integrin α5 are decreased in Ccn2−/− cells planted on FN
(Fig. 3b), but are indistinguishable from WT when plated on VN
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expression seen in isolated Ccn2−/− chondrocytes, type II
collagen levels in intact Ccn2−/− growth plates are
indistinguishable from those in WT growth plates (Ivkovic
et al. 2003). Compensatory mechanisms, possibly involving
other CCN family members, are most likely responsible for
the ability of Ccn2−/− chondrocytes in intact growth plates
and in some isolated cells to produce type II collagen.
Taken together, the results demonstrate that Ccn2 is
required in chondrocytes for normal expression of multiple
cartilage-specific ECM components.
Expression and function of integrin α5 in Ccn2−/−
mutant chondrocytes
It is well known that interactions of integrins with ECM
components are required for cartilage proliferation and
differentiation (Loeser 2002). It has also been shown that
CCN2 binds several types of integrins in fibroblasts and
endothelial cells (Lau and Lam 1999; Brigstock 2003;
Babic et al. 1999; Leu et al. 2003; Chen et al. 2004;
Hoshijima et al. 2006; Tong and Brigstock 2006; Gao and
Brigstock 2005, 2006). Therefore, we examined levels of
expression of various integrin subunits in chondrocytes by
quantitative real-time PCR analysis. We focused on
integrins α1, α5, α10 and β1 because loss-of-function
approaches have revealed roles for these subunits in intact
cartilage in vivo (Aszodi et al. 2003; Garciadiego-Cázares
et al. 2004; Zemmyo et al. 2003; Ekholm et al. 2002;
Bengtsson et al. 2005). Moreover, exogenous CCN2
Fig. 4 CCN2 is a ligand for integrin α5 in primary chondrocytes.
a Complex formation between CCN2 and integrin α5. WT and Ccn2−/−
chondrocytes were cultured until confluent. Lysates of WT and Ccn2−/−
chondrocytes were incubated with antibody against integrin α5, and
proteins were detected by western blot with an anti-CCN2 antibody. b
Lysates of WT and Ccn2−/− chondrocytes were precipitated with heparin
sepharose and integrin α5 and CCN2 were detected by Western blot. c
Adhesion to rCCN2 is impaired by anti-integrin α5 function-blocking
antibodies. Chondrocytes were plated on rCCN2-coated plates treated
with or without blocking antibody. The asterisk indicates a significant
difference (p<0.05) between adhesion on cells in the presence or
absence of the blocking antibody
Fig. 5 Western blot analysis of phospho-FAK and phospho-ERK1/2
in WT and Ccn2 mutant cells. a CCN2 is required for maintenance of
phospho-FAK activity on FN. WT or Ccn2−/− chondrocytes were
inoculated on FN (5 μg/well) at 37°C overnight. Cell lysates were
collected 0.5, 1, 2, 3, or 4 h after inoculation, and immunoprecipitated
with anti-FAK antibody at 4°C overnight. The precipitates were
subjected to SDS-PAGE and Western blot was performed with anti-
phospho-FAK and anti-FAK antibodies. b CCN2 is required for
maintenance of pERK1/2 levels of FN. WT or Ccn2−/− cells were
cultured as above for the indicated times. Immunoprecipitation was
performed with anti-ERK1/2 antibody, followed by detection with
anti-phospho-ERK1/2 and anti-ERK1/2 antibodies. c Ability of
rCCN2 to rescue pMEK1/2 activity in Ccn2−/− chondrocytes plated
on FN. Cells were plated on FN as described above, and maintained in
the absence or presence of rCCN2 at the indicated concentrations for
4 h. Integrin α5 and pMEK1/2 were detected by Western blot analysis
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upregulates integrin α5 expression in normal rat kidney
(NRK) fibroblasts (Frazier et al. 1996), suggesting that
Ccn2−/− chondrocytes might exhibit reduced expression of
this integrin subunit. Indeed, expression of integrin α5 was
decreased in Ccn2−/− chondrocytes compared to WT cells
(Fig. 3a). Expression of integrin α10 showed a trend
towards decreased expression in Ccn2−/− cells, but the
difference did not reach statistical significance. Expression
of the other integrins was not obviously different (Fig. 3a).
To confirm that integrin α5 protein was decreased, we
analyzed protein levels in Ccn2−/− chondrocytes plated on
FN. Figure 3b shows that integrin α5 protein is expressed
at significantly lower levels in Ccn2−/− chondrocytes
compared to WT cells at all time points monitored,
reflecting the decrease observed in mRNA. These results
raised the possibility that CCN2 could be directly involved
in determining the expression level of integrin α5 in
chondrocytes. To investigate this possibility further, we
examined the effects of culturing WT and Ccn2−/−
chondrocytes in the presence of recombinant CCN2 protein
(rCCN2). Both WT and Ccn2−/− chondrocytes exhibited
increased expression of integrin α5 in the presence of
rCCN2 (Fig. 3c), suggesting that CCN2 indeed has a
positive role in regulating levels of integrin α5 expression.
To determine whether the ability of rCCN2 to restore
expression of integrin α5 was a direct or indirect effect, we
investigated whether rCCN2 could increase integrin α5
mRNA levels in WT chondrocytes in the presence of
cycloheximide. Under these conditions, no increased
integrin α5 expression was observed (data not shown),
indicating that new protein synthesis is required for rCCN2
to upregulate integrin α5 levels in chondrocytes.
Integrin α5β1 is the major receptor for FN, and a major
receptor for COMP (cartilage oligomeric matrix protein) in
chondrocytes (Chen et al. 2005). Therefore, we investigated
whether Ccn2−/− chondrocytes exhibit impaired ability to
bind to FN. Figure 3d shows that, consistent with decreased
integrin α5 expression, adhesion of Ccn2−/− chondrocytes
to FN was reduced. The results described above suggest
that Ccn2−/− cells are defective in adhesion to FN, at least
in part because of decreased α5β1 expression. It has been
shown previously that FN-mediated adhesive signaling
maintains integrin α5 expression (Huang et al. 1994;
Larouche et al. 2000), suggesting that the impaired
adhesion to FN seen in Ccn2−/− cells can be both a cause,
and a consequence of, reduced integrin α5 expression, and
that CCN2 plays a direct role in the positive feedback loop
by which FN binding to α5β1 integrin upregulates integrin
α5 expression. If so, integrin α5 levels should be similar in
WT and Ccn2−/− cells plated on VN, which does not
engage integrin α5β1. As previously described, Ccn2−/−
chondrocytes exhibit impaired expression of integrin α5 on
FN (Fig. 3b); however, α5 levels were indistinguishable
between WT and Ccn2−/− cells when they were plated on
VN (Fig. 3e). These results imply that the decreased
adhesion exhibited by Ccn2−/− chondrocytes on FN and
under normal conditions, where they produce their own
matrix, is mediated by α5β1 integrins, and that this
decreased adhesion is responsible for the decreased integrin
α5 expression.
CCN2 physically interacts with α5β1 in fibroblasts
(Chen et al. 2004), hepatic and pancreatic stellate cells (Gao
and Brigstock 2005, 2006) and in a chondrosarcoma-
derived cell line (Hoshijima et al. 2006). Therefore, we
tested whether CCN2 physically interacts with α5β1
integrin in primary chondrocytes. Integrin α5 was precip-
itated from WT and Ccn2−/− chondrocyte lysates, followed
by Western blotting with antibodies against CCN2.
Figure 4a shows that CCN2 can be detected in integrin
α5 precipitates from WT chondrocytes, but not from
Ccn2−/− cells, demonstrating that CCN2 binds integrin α5
in primary chondrocytes. In the absence of an antibody that
precipitates CCN2, we used heparin sepharose to precipi-
tate lysates, because CCN2 binds heparin strongly. As
shown in Fig. 4b, binding of integrin α5 to heparin was
observed in cell lysates from both WT and Ccn2−/−
chondrocytes; however, the intensity of the band was
decreased in lysates from mutant cells, consistent with the
decreased expression of α5 integrin. When these immuno-
precipitates were immunoblotted to detect CCN2, this
protein was clearly present in WT chondrocytes, but absent
in Ccn2−/− chondrocytes. These data demonstrate that
Fig. 6 Immunofluorescence analysis of the actin cytoskeleton in WT
or Ccn2−/− chondrocytes on FN. WT and Ccn2−/− chondrocytes were
spread on FN coated with slides for 1 h or 4 h. The cultures were fixed
with 3.5% formaldehyde, permeabilized with 0.1% NP-40 in PBS, and
stained with phalloidin conjugated to alexa fluor-555 to visualize actin
filaments. Arrows indicate stress fibers
52 T. Nishida, et al.
CCN2 is an endogenous ligand for integrin α5 in
chondrocytes.
In order to test the potential significance of integrin α5
as a receptor for CCN2 in chondrocytes, we examined the
effect of blocking antibodies to integrin α5 on the ability of
these cells to adhere to exogenous CCN2. As shown in
Fig. 4c, adhesion of primary chondrocytes to rCCN2 is
impaired by the integrin α5 blocking antibody. This result
indicates that integrin α5 is a receptor for CCN2 in primary
chondrocytes. Taken together, the data thus suggest that
CCN2 regulates chondrocyte function both as a ligand for
integrin α5, and as a regulator of α5 expression.
CCN2 maintains phosphorylation of FAK and ERK1/2
in chondrocytes
Because expression of integrin α5 and adhesion to FN were
decreased in Ccn2−/− chondrocytes, and CCN2 is known to
activate focal adhesion kinase (FAK) (Chen et al. 2001), we
tested whether adhesive signaling was also impaired in
Ccn2 deficient cells. Ligation of β1 integrins results in
phosphorylation of FAK as it is recruited to focal
adhesions, leading to activation of the downstream extra-
cellular signal-regulated kinase (ERK)1/2 pathway
(Schlaepfer et al. 1999). WT and Ccn2−/− chondrocytes
Fig. 7 Immunofluorescence
analysis of phospho-FAK and
phospho-ERK1/2 in WT or
Ccn2−/− chondrocytes. WT
(a–c, g–i) and Ccn2−/− (d–f, j–l)
chondrocytes were spread on
FN coated slides for 1 h (a–f) or
4 h (g–l). Localization of phos-
pho-FAK (a, d, g, j) and phos-
pho-ERK1/2 (b, e, h, k) was
visualized by indirect immuno-
fluorescence. Microphotographs
of a single field stained with
anti-phospho-FAK (green) and
phospho–ERK1/2 (red) antibod-
ies and with DAPI (c, f, i, l).
The arrows indicate focal adhe-
sions (a and g). Bar represents
50 μm
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were allowed to adhere to FN for various times before
immunoprecipitation analysis with antibodies specific for
total FAK or the phosphorylated (activated) form. At early
time points (up to 2 h) levels of FAK phosphorylation were
similar in WT and Ccn2−/− chondrocytes. However, at later
times the degree of phosphorylation decreased considerably
in the Ccn2−/− chondrocytes (Fig. 5a). Similar results were
obtained when levels of ERK1/2 phosphorylation were
examined (Fig. 5b). To determine whether the decreased
expression of integrin α5 may contribute to the reduced
adhesive signaling in Ccn2−/− chondrocytes, we tested
whether rCCN2 could restore both integrin α5 and
phospho-MEK1/2 levels. As shown in Fig. 5c, rCCN2 at
50 ng/ml and 100 ng/ml increased integrin α5 levels on
chondrocytes plated on FN (Fig. 5c). Moreover, increased
phospho-MEK1/2 levels were observed in the presence of
100 ng/ml rCCN2 (Fig. 5c). The fact that integrin α5 levels
are increased by 50 ng/ml rCCN2, but elevation of
phospho-MEK1/2 levels requires a higher concentration
(100 ng/ml) of rCCN2 raises the likelihood that the ability
of CCN2 to upregulate integrin α5 expression is required,
but that rCCN2 also mediates additional activities to
maintain adhesive signaling in chondrocytes.
Subcellular localization of actin, phosho-FAK,
and phospho-ERK1/2 in Ccn2−/− chondrocytes
The role of CCN2 in adhesive signaling in chondrocytes
was further investigated by indirect immunofluorescence.
WT and Ccn2−/− chondrocytes were seeded on FN for 1 or
4 h before being fixed in formaldehyde, and actin filaments
visualized with phalloidin conjugated to a fluorescent
marker (Fig. 6). The majority of actin is present close to
the cell periphery in WT and Ccn2−/− chondrocytes seeded
for 1 h on FN. After 4 h there are differences between WT
and Ccn2−/− chondrocytes; in WT chondrocytes stress
fibers are evident, whereas in Ccn2−/− cells the majority
of the actin remains close the cell periphery, consistent with
defective adhesive signaling.
To investigate this possibility further, we subjected WT
and Ccn2−/− chondrocytes to double immunostaining with
anti-phospho-FAK and anti-phospho-ERK1/2 antibodies.
Phospho-FAK is a marker for focal adhesions (e.g.,
Almeida et al. 2000; Ruest et al. 2000; Holinstat et al.
2006; Zaidel-Bar et al. 2007). As shown in Fig. 7,
immunoreactivity for phospho-FAK was detected in the
nucleus in both WT and Ccn2−/− chondrocytes after 1 h on
FN, and Western blot analysis revealed similar overall
levels of phospho-FAK (Fig. 5a). However, staining in
focal adhesions was seen only in WT cells (Fig. 7a,d;
arrows). In WT cells, the presence of phospho-FAK in the
nucleus and in focal adhesions persisted after 4 h on FN
(Fig. 7g). However, phospho-FAK could not be detected in
the nucleus or in focal adhesions of Ccn2−/− chondrocytes
after 4 h on FN (Fig. 7j). Indirect immunofluorescence for
vinculin and phospho-tyrosine, additional markers for focal
adhesions (Hamadi et al. 2005; Ballestrem et al. 2006;
Robels and Gomez 2006; Sawada et al. 2006) confirmed
that focal adhesion formation is defective in Ccn2−/−
chondrocytes (Fig. 8). In the case of phospho-ERK1/2,
immunoreactivity was seen in the nucleus and cytoplasm of
WT chondrocytes after 1 h on FN (Fig. 7b), and persisted in
the nucleus after 4 h (Fig. 7h). However, both nuclear and
cytoplasmic staining of phosph-ERK1/2 was reduced in
Ccn2−/− chondrocytes after 1 and 4 h on FN (Fig. 7e,k).
Fig. 8 Focal adhesion forma-
tion in WT and Ccn2−/− chon-
drocytes. a, b WT and Ccn2−/−
chondrocyte, respectively, plated
on FN for 4 h followed by
indirect immunofluorescence
analysis of vinculin expression.
Focal adhesions are seen at the
periphery of the WT cell but not
the mutant cell. c, d WT and
Ccn2−/− chondrocyte, respec-
tively, stained with anti-phos-
photyrosine antibody (PY-20)
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These findings are consistent with the results in Fig. 5 and
indicate that cell signaling through integrin receptors for FN
via phospho-FAK and phospho-ERK1/2 is maintained in
WT, but not in Ccn2−/− chondrocytes.
Immunolocalization of integrin α5 in WT and Ccn2−/−
growth plates
Our data suggest that CCN2 is essential for ECM
production and both induces the expression of integrin
α5, and binds to it. To determine whether decreased
expression of ECM components and/or integrin α5 might
contribute to the chondrodysplaisa observed in Ccn2−/−
mice, we examined proteoglycan production and the
localization of integrin α5 in endochondral bone. As shown
in Fig. 9, an enlarged hypertrophic zone was seen in the
growth plate in Ccn2−/− mice compared to WT littermates
(panels a and b), consistent with previous studies (Ivkovic
et al. 2003). Safranin-O staining revealed reduced levels of
proteoglycans in cartilage throughout Ccn2−/− growth
plates (Fig. 9a and b). This finding is consistent with the
results shown in Fig. 2 and with previous studies indicating
that aggrecan levels are reduced in Ccn2−/− growth plates
(Ivkovic et al. 2003). In accordance with previous studies
(Loeser 2002), immunoreactivity for integrin α5 was
detected throughout the WT growth plate, with highest
levels in the prehypertrophic and hypertrophic zones
(Fig. 9c). This pattern of expression corresponds closely
with that of CCN2 in the growth plate; CCN2 is expressed
at low levels in proliferating chondrocytes and at much
higher levels in the hypertrophic zone (Ivkovic et al. 2003;
Nishida et al. 2002). The pattern of integrin α5 expression
is significantly reduced in Ccn2−/− mice, with the greatest
reduction in the hypertrophic zone chondrocytes (Fig. 9
compare panels c and d). The finding that integrin α5
expression is reduced in Ccn2−/− growth plates, and this
reduction is most evident in the hypertrophic zone, which
normally expresses the highest levels of CCN2, strongly
suggests that integrin α5 is a major mediator of the effects
of CCN2 in vivo in chondrocytes.
Discussion
Previous studies have shown that CCN2 is an essential
regulator of chondrogenesis (Ivkovic et al. 2003). Chon-
drocyte proliferation, ECM composition, matrix remodeling
and growth plate angiogenesis are all impaired in Ccn2−/−
growth plates. The mechanisms by which loss of CCN2
leads to these defects are unknown. We have investigated
potential mechanisms of action of CCN2 in chondrocytes in
this report.
We find that chondrocytes isolated from Ccn2−/− mice
exhibit impaired type II collagen and aggrecan expression,
matrix synthesis, and proliferation, consistent with and
extending our previous findings in vivo (Ivkovic et al.
2003). Moreover, we find that CCN2 is an essential
regulator of integrin α5 expression and function in
chondrocytes. We show here that rCCN2 induces integrin
α5 expression, and that endogenous CCN2 is required for
normal levels of integrin α5 expression in chondrocytes.
Fig. 9 Immunolocalization of
α5β1 integrin in sections of
growth plate cartilage of WT
and Ccn2−/− mice. Sections of
growth plates of E18.5 femurs at
identical levels in WT and
Ccn2−/− littermates were stained
with safranin-O (a, b), and
reacted with anti-α5β1 integrin
(c, d). The primary antibodies
were visualized by immunoper-
oxidase, and then the sections
were counterstained with methyl
green. α5β1 integrin was local-
ized throughout the growth
plate, with highest levels of
expression in the hypertrophic
zone (HZ) of the WT growth
plate. Lower levels of expres-
sion are seen in the hypertrophic
zone in the mutant growth plate.
Bar represents 100 μm
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Recently, it was reported that blocking α5β1 integrin
function in vivo inhibits pre-hypertrophic chondrocyte
differentiation (Garciadiego-Cázares et al. 2004). In this
study, we show that decreased expression of integrin α5 in
Ccn2−/− chondrocytes correlates with defective chondro-
cyte differentiation and ECM production in vitro and in
vivo. Interestingly, the expression pattern of integrin α5 in
the cartilage strongly resembles that previously shown for
CCN2 (Nakanishi et al. 2000; Ivkovic et al. 2003; Nishida
et al. 2002). This strongly suggests a potential role for
CCN2 as an endogenous regulator of integrin α5 expres-
sion. However, CCN2 cannot be the only regulator of
integrin α5 expression in cartilage because it is clearly
present in Ccn2−/− growth plates (Fig. 9), and isolated
Ccn2−/− primary chondrocytes retain low levels of integrin
α5 expression (Fig. 3a,b). It is conceivable that the related
family member CCN1 (CYR61), which is expressed in
proliferative and pre-hypertrophic chondrocytes (Wong et
al. 1997), can compensate at least in part for loss of Ccn2
and is responsible for the residual level of integrin α5
expression. We conclude that regulation of integrin α5
expression represents one, but not the only, mechanism
underlying the requirement for CCN2 in chondrogenesis.
That additional mechanisms of CCN2 action are responsi-
ble for the defects in adhesive signaling in Ccn2 mutant
chondrocytes is further suggested by the finding that
rCCN2 at 50 ng/ml can rescue integrin α5 expression, but
not phospho-MEK1/2 levels (Fig. 5).
We have shown that CCN2 is present in a complex with
integrin α5 in chondrocytes. Our data support the hypoth-
esis that CCN2 is required for efficient signaling by integrin
α5 in chondrocytes. Although initial phosphorylation of
FAK and ERK1/2 appears to be normal in Ccn2−/−
chondrocytes, the signal is transient compared to the
persistence of these signals in WT cells. The basis for this
inability of mutant chondrocytes to maintain phospho-FAK
and phospho-ERK1/2 at normal levels is currently un-
known, but warrants investigation in the future. Immuno-
fluorescence studies verified defective focal adhesion
formation in Ccn2−/− chondrocytes. In addition, there are
significant phenotypic similarities in the defects observed in
Ccn2−/− growth plates and those in mice that lack
expression of integrin β1 (Aszodi et al. 2003). Taken
together, these data are consistent with the hypothesis that
CCN2 is required for integrin-mediated signaling in
chondrocytes, particularly through integrin α5β1. Our data
show that CCN2 not only induces integrin α5 expression
(Fig. 3c) and is required for normal expression levels in
vivo (Fig. 9), but that integrin α5 also interacts directly
with CCN2 in chondrocytes (Fig. 4).
It has been shown that expression of integrin α5 is up-
regulated by exogenous CCN2 in fibroblasts (Frazier et al.
1996; Weston et al. 2003). Recently, Chen et al. investigated
cell adhesion to fibronectin using Ccn2−/− embryonic
fibroblasts, and showed that loss of endogenous CCN2
resulted in impaired spreading on fibronectin, delayed stress
fiber formation, and reduced FAK and ERK1/2 phosphor-
ylation (Chen et al. 2004). Interestingly, in contrast to our
finding that integrin α5 mRNA and protein levels are
reduced in Ccn2−/− chondrocytes (Fig. 3a,b), no such effect
on α5 integrin transcription was observed in Ccn2−/−
fibroblasts (Chen et al. 2004). However, our results are
consistent with other reports that α5 integrin signaling
induces α5 integrin transcription (Huang et al. 1994). The
observation that FAK and ERK1/2 cannot be maintained in
Ccn2−/− chondrocytes (Figs. 5 and 7) provides strong
support for the hypothesis that the chondrodysplasia
observed in Ccn2−/− growth plates is due at least in part
to defective integrin-ECM interactions.
In conclusion, CCN2 is an essential regulator of ECM
expression and both the expression and signaling properties
of integrin α5; moreover CCN2 mediates signaling through
the activation of ERK1/2 via integrin signaling in chon-
drocytes. The phenotypic correspondence between β1
integrin-deficient mice (Aszodi et al. 2003) and Ccn2−/−
mice (Ivkovic et al. 2003) is consistent with the possibility
that a primary mode of action for CCN2 is through its
ability to regulate integrin signaling.
CCN2 has been proposed to bind directly to a variety of
growth factors, including Transforming growth factor
(TGF)-β, Bone morphogenetic proteins (BMPs), and
vascular endothelial growth factor (VEGF), all of which
have profound effects on the growth plate (Serra et al.
1997; Inoki et al. 2002; Abreu et al. 2002; Zelzer et al.
2002; Yoon et al. 2005, 2006; Baffi et al. 2006). Future
studies will be required to determine the physiological
relevance of these activities of CCN2, to determine whether
CCN2 exerts overlapping functions with other CCN family
members in cartilage, and to detect additional functions for
CCN2 in other aspects of disease and development.
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